Trius Therapeutics Inc 4
4 · Trius Therapeutics Inc · Filed Jun 3, 2013
Insider Transaction Report
Form 4
Prokocimer Philippe
Chief Medical Officer
Transactions
- Sale
Common Stock
2013-06-03$7.75/sh−2,000$15,500→ 84,022 total(indirect: By Trust)
Holdings
- 10,865
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2012
- [F2]Includes 436 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 5/20/13.